Home > Insider Trading > Filing (0001415889-24-028563)

Filing Details

Accession Number:: 0001415889-24-028563
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-12-06 19:12:27
Reporting Period:: 2024-12-06

Accepted Time:: 2024-12-06 19:12:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1534133	Calcimedica Inc.	CALC	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1267959	A Fred Middleton	C/O Calcimedica, Inc. 505 Coast Blvd. S. #307 La Jolla CA 92037		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-12-06	4,800	$2.65	36,514	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	814,300	Indirect	By Sanderling Venture Partners VI Co-Investment Fund, L.P.
Common Stock	946,744	Indirect	By Sanderling Venture Partners VI, LP
Common Stock	22,479	Indirect	By Sanderling Ventures Management VI
Common Stock	7,456	Indirect	By Sanderling VI Beteligungs GmbH & Co KG
Common Stock	8,884	Indirect	By Sanderling VI Limited Partnership
Common Stock	435,148	Indirect	By Sanderling Ventures VII, L.P.
Common Stock	114,260	Indirect	By Sanderling Ventures VII (Canada), L.P.
Common Stock	27,609	Indirect	By Sanderling Ventures VII Annex Fund, L.P.
Common Stock	30,292	Indirect	By Sanderling Ventures Management VII
Common Stock	8,176	Indirect	By Golden Triangle Ventures, LLC

Footnotes

The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the securities of the Issuer held by Sanderling Venture Partners VI Co-Investment Fund, LP ("SVP VI Co-Investment, LP", together with Sanderling Venture Partners VI, LP., Sanderling VI Beteiligungs GmbH & Co. KG, Sanderling Ventures Management VI and Sanderling VI Limited Partnership (the "Sanderling VI Securities"). The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the Sanderling VI Securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the securities of the Issuer held by Sanderling Ventures VII, LP ("SVP VII, LP", together with Sanderling Ventures Management VII, Sanderling Ventures VII (Canada), L.P. and Sanderling Ventures VII Annex Fund, L.P., the "Sanderling VII Securities"). The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the Sanderling VII Securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
The Reporting Person is a managing member of Golden Triangle Ventures LLC and may be deemed to beneficially own the securities of the Issuer held by Golden Triangle Ventures LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.